retatrutide efficacy clinical trials and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 retatrutide efficacy vs. Tirzepatide: The
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19




















![Turning Point Hub Kit #715 [11701500] Boat Outfitting | Accessories](https://cdn.shopify.com/s/files/1/0559/7800/0581/products/67797XL.jpg?v=1617420265)




